164 related articles for article (PubMed ID: 35150157)
21. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
22. Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
Sarafoglou K; Barnes CN; Huang M; Imel EA; Madu IJ; Merke DP; Moriarty D; Nakhle S; Newfield RS; Vogiatzi MG; Auchus RJ
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4666-e4679. PubMed ID: 34146101
[TBL] [Abstract][Full Text] [Related]
23. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency.
Stikkelbroeck NM; Sweep CG; Braat DD; Hermus AR; Otten BJ
Fertil Steril; 2003 Oct; 80(4):1030-6. PubMed ID: 14556829
[TBL] [Abstract][Full Text] [Related]
25. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
26. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
Sarafoglou K; Himes JH; Lacey JM; Netzel BC; Singh RJ; Matern D
Horm Res Paediatr; 2011; 75(1):19-25. PubMed ID: 20798478
[TBL] [Abstract][Full Text] [Related]
27. Is there an association between prostate-specific antigen and androgen levels in 46, XX patients with congenital adrenal hyperplasia?
de Almeida RB; Apóstolos RAC; Oliveira LMB; Toralles MBP; Lago RMRS; Faria JAD; Arruti RA; Rodrigues MLB; Amorim T; Dos Santos HMGP; de Sousa LA; Barroso U
J Pediatr Urol; 2021 Aug; 17(4):481.e1-481.e7. PubMed ID: 34092513
[TBL] [Abstract][Full Text] [Related]
28. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
El-Maouche D; Merke DP; Vogiatzi MG; Chang AY; Turcu AF; Joyal EG; Lin VH; Weintraub L; Plaunt MR; Mohideen P; Auchus RJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):2771-8. PubMed ID: 32589738
[TBL] [Abstract][Full Text] [Related]
29. Measuring steroids in hair opens up possibilities to identify congenital adrenal hyperplasia in developing countries.
Waaijers S; Utari A; van der Doelen RHA; Faradz SMH; Hensen-Lodewijk R; Olthaar AJ; Geutjes PJ; Sweep FC; Claahsen-van der Grinten HL; van Herwaarden AE
Clin Endocrinol (Oxf); 2023 Jan; 98(1):41-48. PubMed ID: 35514026
[TBL] [Abstract][Full Text] [Related]
30. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
Pussard E; Travers S; Bouvattier C; Xue QY; Cosson C; Viengchareun S; Martinerie L; Lombès M
J Steroid Biochem Mol Biol; 2020 Apr; 198():105553. PubMed ID: 31778802
[TBL] [Abstract][Full Text] [Related]
31. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
Zerah M; Pang SY; New MI
J Clin Endocrinol Metab; 1987 Aug; 65(2):227-32. PubMed ID: 3496350
[TBL] [Abstract][Full Text] [Related]
32. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
[TBL] [Abstract][Full Text] [Related]
33. Effect of complete suppression of androstenedione on auxological development in prepubertal patients with classical congenital adrenal hyperplasia.
Debor B; Bechtold-Dalla Pozza S; Reisch N; Schmidt H; Dubinski I
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):930-940. PubMed ID: 37650550
[TBL] [Abstract][Full Text] [Related]
34. An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia.
Al-Kofahi M; Ahmed MA; Jaber MM; Tran TN; Willis BA; Zimmerman CL; Gonzalez-Bolanos MT; Brundage RC; Sarafoglou K
Br J Clin Pharmacol; 2021 Mar; 87(3):1098-1110. PubMed ID: 32652643
[TBL] [Abstract][Full Text] [Related]
35. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
Birkebaek NH; Hougaard DM; Cohen AS
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):85-88. PubMed ID: 27977405
[TBL] [Abstract][Full Text] [Related]
36. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
Newfield RS; Sarafoglou K; Fechner PY; Nokoff NJ; Auchus RJ; Vogiatzi MG; Jeha GS; Giri N; Roberts E; Sturgeon J; Chan JL; Farber RH
J Clin Endocrinol Metab; 2023 Oct; 108(11):2871-2878. PubMed ID: 37216921
[TBL] [Abstract][Full Text] [Related]
37. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
Hampl R; Foretová L; Sulcová J; Stárka L
Eur J Pediatr; 1990 Jan; 149(4):232-4. PubMed ID: 2303071
[TBL] [Abstract][Full Text] [Related]
38. Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia: utility of salivary 17α-hydroxyprogesterone day profiles.
Deutschbein T; Unger N; Hauffa BP; Schaaf K; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2011 Mar; 119(3):131-8. PubMed ID: 20690075
[TBL] [Abstract][Full Text] [Related]
39. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M; Mallappa A; Gounden V; Nella AA; Harrison RF; Crutchfield CA; Backlund PS; Soldin SJ; Ross RJ; Merke DP
Eur J Endocrinol; 2015 Dec; 173(6):727-37. PubMed ID: 26340969
[TBL] [Abstract][Full Text] [Related]
40. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
